MIT Technology Review June 23, 2021
Maryn McKenna

We’ve known the dangers of antimicrobial resistance for years. What if we used what we learned from covid to tackle it?

It was August 2017, and pleasant and breezy in the central mountains of Madagascar. The passengers loading their bags into the minibus leaving Ankazobe, a small town in the highlands, were grateful for the morning coolness. It would be warm and sticky on the trip they were taking to Antananarivo, the island’s million-person capital 100 kilometers to the south, and then to Toamasina on the coast, another 350 kilometers away. One of the passengers, a 31-year-old man, looked uncomfortable already. Four days before, he had arrived on a visit. Now he was headed...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
The Tobacco Endgame Begins
Opinion: Measles is coming back. My sister Marcie isn’t
Lab practices go under the microscope
Opinion: As livestock move around the country, so does H5N1. The U.S. needs real-time tracking of livestock movements
Podcast: Charles Stoecker on How Guaranteed Cash Incentives Boosted COVID-19 Vaccinations

Share This Article